Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit Hepatitis B virus in a stable HBV-producing cell line

American Journal of Chinese Medicine

Volumn 35, Issue 2, 2007, Pages 341-351

  Chang, Jung San ^a   Wang, Kuo Chih ^b   Liu, Hong Wen ^c   Chen, Mei Chun ^c   Chiang, Lien Chai ^c   Lin, Chun Ching ^c  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chronic Hepatitis B; HepG2; PCR; Saikosaponin; TaqMan; Xiano Chai Hu Tang

Indexed keywords

ANTIVIRUS AGENT; BUPLEURUM CHINENSE EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PINELLIA TERNATE EXTRACT; PLANT EXTRACT; SAIKOSAPONIN; SAIKOSAPONIN A; SAIKOSAPONIN C; SAIKOSAPONIN D; UNCLASSIFIED DRUG; VIRUS ANTIGEN; XIAO CHAI HU TANG; ZIZYPHUS VULGARIS EXTRACT;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BUPLEURUM; BUPLEURUM CHINENSE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IC 50; JUJUBE; MEDICINAL PLANT; PHYTOCHEMISTRY; PINELLIA; PINELLIA TERNATE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT INFECTION; VIRUS INHIBITION; ZIZYPHUS VULGARIS;

CELL LINE; DNA, VIRAL; DRUGS, CHINESE HERBAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; OLEANOLIC ACID; PLANT EXTRACTS; SAPONINS; VIRUS REPLICATION;

EID: 34147213589     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X07004862     Document Type: Article

References (30)

1. Akbar, S.M., K. Yamamoto, M. Abe, T. Ninomiya, K. Tanimoto, T. Masumoto, K. Michitaka, N. Horiike and M. Onji. Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier. Eur. J. Clin. Invest. 29(9): 786-792, 1999.
2. Ayoola, E.A., M.S. Balayab, F. Deinhardt, I. Gust, A.W. Kureshi and J.E. Maynard. Bull. World Health Organ. 66: 443-455, 1988.
3. Chang, J.S., H.W. Liu, K.C. Wang, M.C. Chen, L.C. Chiang, Y.C. Hua and C.C. Lin. Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antiviral Res. 66: 29-34, 2005.
4. Chiang, L.C., L.T. Ng, L.T. Liu, D.E. Shieh and C.C. Lin. Cytotoxicity and anti-hepatitis B virus activity of saikosaponins from Bupleurum species. Planta Med. 69: 705-709, 2003.
5. Dienstag, J.L. and K.J. Isselbacher. Chronic hepatitis. In: E. Braunwald, A.S. Fauci, D.L. Kasper, S.L. Hauser, D.L. Longo and J.L. Jameson (eds.) Harrison's Principle of Internal Medicine. McGraw-Hill, New York, 2005a, pp. 1844-1855.
6. Dienstag, J.L. and K.J. Isselbacher. Tumors of the liver and biliary tract. In: E. Braunwald, A.S. Fauci, D.L. Kasper, S.L. Hauser, D.L. Longo and J.L. Jameson (eds.) Harrison's Principle of Internal Medicine. McGraw-Hill, New York, 2005b, pp. 533-536.
7. Farrell, G.C. Clinical potential of emerging new agents in hepatitis B. Drugs 60: 701-710, 2000.
8. Hirayama, C., M. Okumura, K. Tanikawa, M. Yano, M. Mizuta and N. Ogawa. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. Gastroenterol. Jpn. 24: 715-719, 1989.
9. Hollinger, F.B. and T.J. Liang. Hepatitis B virus. In: B.N. Fields, D.M. Knipe and P.M. Howley (eds.) Fields Virology. Lippincott-Raven, Philadelphia, 1996, pp. 2971-3036.
10. Huang, X.X., M. Yamashiki, K. Nakatani, T. Nobori and A. Mase. Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system. J. Clin. Lab. Anal. 15: 199-209, 2001.
11. Innaimo, S.F., M. Seifer, G.S. Bisacchi, D.N. Standring, R. Zahler and R.J. Colonno. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob. Agents Chemother. 41: 1444-1448, 1997.
12. Ito, H. and K. Shimura, Effects of a blended Chinese medicine, xiao-chai-hu-tang, on Lewis lung carcinoma growth and inhibition of lung metastasis, with special reference to macrophage activation. Jpn. J. Pharmacol. 41: 307-314, 1986.
13. Kakumu, S., K. Yoshioka, T. Wakita and T. Ishikawa. Effects of TJ-9 Shosaiko-to (Kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis. Int. Immunopharmacol. 13: 141-146, 1991.
14. Kayano, K., I. Sakaida, K. Uchida and K. Okita. Inhibitory effects of the herbal medicine Sho-saikoto (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. J. Hepatol. 29: 642-649, 1998.
15. Liaw, Y.F. Therapy of chronic hepatitis B: Current challenges and opportunities. J. Viral Hepat. 9: 393-399, 2002.
16. Mahoney, F.J. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin. Microbiol. Rev. 12; 351-366, 1999.
17. Ohta, Y., K. Nishida, E. Sasaki, M. Kongo, T. Hayashi, M. Nagata and I. Ishiguro. Comparative study of oral and parenteral administration of sho-saiko-to (xiao-chaihu-tang) extract on D-galactosamine-induced liver injury in rats. Am. J. Chin. Med. 25: 333-342, 1997.
18. Oka, H., A. Yamamoto, T. Kuroki, S. Harihara, T. Marumo, S.R. Kim and T. Monna. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 76: 743-749, 1995.
19. Ono, K., H. Nakane, M. Fukushima, J.C. Chermann and F. Barre-Sinoussi. Differential inhibition of the activities of reverse transcriptase and various cellular DNA polymerases by a traditional Kampo drug, sho-saiko-to. Biomed. Pharmacother. 44: 13-16, 1990.
20. Ono, M., M. Miyamura, S. Kyotani, T. Saibara, S. Ohnishi and Y. Nishioka. Effect of Sho-saiko-to extract on HGF and TGF-beta levels of intraorgans in liver-injured rats after partial hepatectomy. J. Pharm. Pharmacol. 52: 111-118, 2000.
21. Piras, G., M. Makino and M. Baba. Sho-saiko-to, a traditional Kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro. Microbiol. Inmmunol. 41: 835-839, 1997.
22. Sakaida, I., Y. Matsumura, S. Akiyama, K. Hayashi, A. Ishige and K. Okita. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J. Hepatol. 28: 298-306, 1998.
23. Sells, M.A., M.L. Chen and G. Acs. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84: 1005-1009, 1987.
24. Shimizu, I., Y.R. Ma, Y. Mizobuchi, F. Liu, T. Miura, Y. Nakai, M. Yasuda, M. Shiba, T. Horie, S. Amagaya, N. Kawada, H. Hori and S. Ito. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160, 1999.
25. Shiota, G., Y. Maeta, T. Mukoyama, A. Yanagidani, A. Udagawa, K. Oyama, K. Yashima, Y. Kishimoto, Y. Nakai, T. Miura, H. Ito, Y. Murawaki and H. Kawasaki. Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2′-deoxyguanosine formation. Hepatology 35: 1125-1133, 2002.
26. Tajiri, H., K. Kozaiwa, Y. Ozaki, T. Harada, K. Miki, K. Shimizu and S. Okada. The study of the effect of Sho-saiko-to on HbsAg clearance in children with chronic HBV infection and with abnormal liver function test. Acta Paediatr. Jpn. 94: 1811-1815, 1990.
27. Yamashiki, M., A. Nishimura, H. Suzuki, S. Sakaguchi and Y. Kosaka. Effects of the Japanese herbal medicine "Sho-saiko-to" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology 25: 1390-1397, 1997a.
28. Yamashiki, M., A. Nishimura, T. Nobori, S. Nakabayashi, T. Takagi and K. Inoue. In vitro effects of sho-saiko-to on production of granulocyte colony-stimulating factor by mononuclear cells from patients with chronic hepatitis C. Int. J. Immunopharmacol. 19: 381-385, 1997b.
29. Yano, H., A. Mizoguchi, K. Fukuda, M. Haramaki, S. Ogasawara, S. Momosaki and M. Kojiro. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 54: 448-454, 1994.
30. Yen, M.H., C.C. Lin, C.H. Chuang and S.Y. Liu. Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of "xiao-chai-hu-tang" prepared using three different Bupleurum species. J. Ethnopharmacol. 34: 155-165, 1991.